0001209191-15-073541.txt : 20151002 0001209191-15-073541.hdr.sgml : 20151002 20151002193445 ACCESSION NUMBER: 0001209191-15-073541 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151002 FILED AS OF DATE: 20151002 DATE AS OF CHANGE: 20151002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARATANA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001509190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383826477 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1901 OLATHE BOULEVARD CITY: KANSAS CITY STATE: KS ZIP: 66103 BUSINESS PHONE: 913.951.2130 MAIL ADDRESS: STREET 1: 1901 OLATHE BOULEVARD CITY: KANSAS CITY STATE: KS ZIP: 66103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TOOMAN CRAIG A CENTRAL INDEX KEY: 0001201050 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35952 FILM NUMBER: 151141835 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-10-02 0 0001509190 ARATANA THERAPEUTICS, INC. PETX 0001201050 TOOMAN CRAIG A C/O ARATANA THERAPEUTICS, INC. 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 0 1 0 0 CHIEF FINANCIAL OFFICER COMMON STOCK 2015-10-02 4 S 0 3250 8.058 D 73600 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2015, and represents shares sold to cover tax liability incident to the vesting of shares of restricted stock. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.05 to $8.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ John C. Ayres as Attorney-in-Fact for Craig Tooman 2015-10-02